Le Lézard
Classified in: Health
Subjects: PDT, SVY, FVT

Phigenics announces new Water Management for Construction services to advance facility operations for building water safety in alignment with industry standards


WARRENVILLE, Ill., Jan. 16, 2020 /PRNewswire/ -- Phigenics announces the introduction of their new phiConstruction? service offering. phiConstruction addresses Water Management for Construction (WMC) to manage known construction risk factors within an organization's water management program (WMP). The service allows building owners to reduce the potential for growth and spread of Legionella and other waterborne pathogens in building water systems for alignment with ANSI/ASHRAE Standard 188:2018. To achieve alignment with industry standards such as ANSI ASHRAE 188:2018, building owners are required to perform WMP surveys for existing buildings, and surveys prior to any renovation, addition or modification to an existing building, as well as prior to occupancy of any new building.

(PRNewsfoto/Phigenics)

A recent study examined connections between construction activities and waterborne pathogens. As principal investigator, Dr. Molly Scanlon, FAIA, FACHA, Phigenics Director of Standards, Compliance, and Research, found Legionella has a 50 year history of association with construction risk factors. "Based on our review of scientific literature, construction activities have been associated with disease cases linked to waterborne pathogens since 1965. Our team's findings suggest the time period between the start-up of the building water distribution system during construction, and first business day of operations, involves a critical schedule of events to reduce risk. A comprehensive water management program inclusive of construction activities should be implemented to reduce the risk of disease cases from Legionella and other waterborne pathogens. Although many building owners are implementing water management programs, we find few understand the risks associated with construction activities. This is especially important for healthcare providers performing construction activities within and near patient care settings treating immunocompromised patients." 

Phigenics integrates risk management, facilities management, planning design & construction, infection prevention, and real estate management professionals for defensible consistency within the phiConstruction service offering.  phiConstruction service offering includes Water Management for Construction (WMC) Policy Audits, WMC During Construction Activities, and WMC During Commission Activities.

Phigenics works with water management teams to address water safety issues during construction activities, including: alignment with ANSI/ASHRAE 188: 2018, water service disruptions, soil/sediment invasion of water systems, proper flushing and disinfection of water systems, and water management commissioning from beneficial occupancy through the first business day of operations.

Those interested in learning more about Phigenics phiConstruction services please visit:  https://info.phigenics.com/phiconstruction.  Phigenics will be hosting a public webinar featuring Dr. Molly Scanlon on March 12, 2020 at 10am central time.  Registration will be opening in early February and will be accessible through phigenics.com.

About Phigenics
Phigenics, the Independent Leader in Water Management, sells comprehensive water management programs. Facility managers and building owners use these programs to optimize the total cost of their water systems by improving safety and efficiency. These programs include regulatory compliance, data management and water testing analytical services. As a non-conflicted, third party, Phigenics provides independent verification and validation that programs are defensible and water management program goals have been achieved in the most cost-effective manner.

Contact: Monica Keil, [email protected] 1-844-850-4087

 

SOURCE Phigenics, LLC


These press releases may also interest you

at 16:05
Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a global messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases, today...

at 16:05
Stevanato Group S.p.A. , a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will issue financial results for the first...

at 16:05
Bruker Corporation today announced it will report first quarter 2024 financial results before market opening on Thursday, May 2, 2024. The Company will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss the results and current...

at 16:05
Gilead Sciences, Inc. announced today its first quarter 2024 results of operations. "Gilead delivered another strong quarter of revenue growth in the first quarter with 6% year-over-year growth in our base business driven by HIV, Oncology and...

at 16:05
DexCom, Inc. today reported its financial results as of and for the quarter ended March 31, 2024. First Quarter 2024 Financial Highlights: Revenue grew 24% year-over-year to $921.0 million on a reported basis and 25% year-over-year on an...

at 16:05
Ironwood Pharmaceuticals, Inc. today announced it will host its first quarter 2024 investor update conference call and webcast at 8:30 a.m. Eastern Time on Thursday, May 9, 2024. Individuals interested in participating in the call should dial (888)...



News published on and distributed by: